Company Filing History:
Years Active: 2019
Title: Etienne Thierry Charles Rogeau - Innovating in Polyunsaturated Fatty Acid Formulations
Introduction: Etienne Thierry Charles Rogeau, an accomplished inventor from Beinheim, France, has made significant contributions to the field of pharmaceutical formulations. Known for his innovative approaches, Rogeau has developed a unique patent that enhances the delivery of polyunsaturated free fatty acids through novel dosage forms.
Latest Patents: Rogeau holds a patent for "Millicapsule formulations comprising polyunsaturated free fatty acids." This patent describes capsular dosage forms containing compositions of polyunsaturated fatty acids (PUFA). The invention emphasizes the utility of unit dosage forms that include a plurality of millicapsules, each containing PUFA compositions. Notably, certain embodiments highlight the inclusion of PUFA compositions in their free acid form, with Epanova® being a specific example of such compositions.
Career Highlights: Rogeau works with Omthera Pharmaceuticals Inc., a company dedicated to advancing treatments through innovation. His expertise in formulation science has positioned him as a pivotal figure in developing effective and accessible treatments for patients.
Collaborations: Throughout his career, Rogeau has collaborated with esteemed colleagues, including Hironori Kubota and Tohru Amemiya. These partnerships have fostered a dynamic environment for scientific inquiry and technological advancement, contributing to notable developments in the pharmaceutical sector.
Conclusion: Etienne Thierry Charles Rogeau stands out as a remarkable innovator in the realm of polyunsaturated fatty acid formulations. His patented work not only represents a significant advancement in pharmaceutical delivery systems but also embodies the collaborative spirit of modern scientific research. Through his continued efforts and collaborations, Rogeau is poised to make further contributions to the field of medicine and health.